Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-06

Clinical Trial Update: Maintenance Therapy Using Lenalidomide in Myeloma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating maintenance therapy with lenalidomide in multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lenalidomide (lenalidomide)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Myeloma | Phase 3 | Status: COMPLETED